Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002807330 | SCV003196347 | pathogenic | Deficiency of hydroxymethylglutaryl-CoA lyase | 2022-05-21 | criteria provided, single submitter | clinical testing | This variant is present in population databases (no rsID available, gnomAD 0.006%). This sequence change creates a premature translational stop signal (p.Ile60Phefs*9) in the HMGCL gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HMGCL are known to be pathogenic (PMID: 9817922, 17692550, 23465862). This variant has not been reported in the literature in individuals affected with HMGCL-related conditions. For these reasons, this variant has been classified as Pathogenic. |